THBS1 and complement factor, in combination with other protein markers, were initially demonstrated as blood biomarker for prostate cancer by Cima et al., 2011, to accurately predict 78% of patients with aberrant or normal PTEN status with an AUC of 0.82 [52]. The gene discussed is THBS1; the disease is prostate cancer.